Relugolix - new treatment for uterine fibroid-related heavy bleeding

Affiliations

¹ Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC, USA. baird@niehs.nih.gov.
² Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC, USA.

Comment

Donna D Baird et al. Nat Rev Endocrinol. 2021 Jun.

. 2021 Jun;17(6):321-322.

doi: 10.1038/s41574-021-00493-2.

¹ Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC, USA. baird@niehs.nih.gov.
² Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC, USA.

No abstract available

Comment on

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA. Al-Hendy A, et al. N Engl J Med. 2021 Feb 18;384(7):630-642. doi: 10.1056/NEJMoa2008283. N Engl J Med. 2021. PMID: 33596357 Free PMC article. Clinical Trial.

1. Stewart, E. A. et al. Uterine fibroids. Nat. Rev. Dis. Primers 2, 16043 (2016). - DOI
1. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet. Gynecol. 112, 387–400 (2008). - DOI
1. Al-Hendy, A. et al. Treatment of uterine fibroid symptoms with relugolix combination therapy. N. Engl. J. Med. 384, 630–642 (2021). - DOI
1. Lewis, T. D., Malik, M., Britten, J., San Pablo, A. M. & Catherino, W. H. A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma. Biomed. Res. Int. 2018, 2414609 (2018). - DOI
1. Farris, M., Bastianelli, C., Rosato, E., Brosens, I. & Benagiano, G. Uterine fibroids: an update on current and emerging medical treatment options. Ther. Clin. Risk Manag. 15, 157–178 (2019). - DOI